EczemaLess
PrivateCompany Overview
EczemaLess operates in Healthcare & Life Sciences and is based in Austin, Texas. It was founded in 2018.
EczemaLess is a digital health company that provides an AI-enabled mobile application for tracking and managing atopic dermatitis symptoms, triggers, and care routines.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Patient Engagement, Healthcare Analytics
Business Model
B2C
Customer Profile
Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EczemaLess Comparables
Compare EczemaLess with similar companies based on industry and business-model similarity.
No comparables are published for EczemaLess. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
EczemaLess Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 76% MoM.
- Mar 1, 2026
Monthly visitors increased 351% MoM, reaching 10.8K.
For institutional investors. Book with your work email.
EczemaLess Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EczemaLess's valuation, stock price, and market status.
Is EczemaLess a public or private company?
EczemaLess is a private company.
What is the current stock price of EczemaLess?
EczemaLess is a private company, so its shares have no public market price. Caplight tracks EczemaLess's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EczemaLess worth (valuation)?
Valuation information for EczemaLess is not publicly available.
Can I buy EczemaLess stock?
EczemaLess shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EczemaLess's last funding round?
Funding round information for EczemaLess is not publicly available.
Who are the main investors in EczemaLess?
Investor information for EczemaLess is not publicly disclosed.
Will EczemaLess IPO soon?
No public IPO plans have been announced for EczemaLess.
How can I track EczemaLess secondary market activity?
Caplight tracks bids, offers, and trades in EczemaLess's shares on secondary markets.